Michael B Barton
Overview
Explore the profile of Michael B Barton including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
1042
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fukushima A, Hande V, Wakeham K, Barton M, Zaghloul M, Moreira D, et al.
Radiother Oncol
. 2024 May;
197:110343.
PMID: 38806114
Background And Purpose: The optimal utilization rate of radiotherapy (oRUR) serves as a benchmark for assessing service demand and improving access to cancer care. While it is estimated that approximately...
2.
Wilson B, Booth C, Sullivan R, Aggarwal A, Sengar M, Jacob S, et al.
Lancet Oncol
. 2023 Jun;
24(6):682-690.
PMID: 37269845
Background: Resource-stratified guidelines (RSGs) can inform systemic treatment decisions in the face of limited resources. The objective of this study was to develop a customisable modelling tool to predict the...
3.
Batumalai V, Descallar J, Gabriel G, Delaney G, Oar A, Barton M, et al.
Asia Pac J Clin Oncol
. 2022 Oct;
19(3):415.
PMID: 36300540
No abstract available.
4.
Rai R, Barton M, Chlap P, Liney G, Brink C, Vinod S, et al.
J Med Imaging (Bellingham)
. 2022 Aug;
9(4):044005.
PMID: 35992729
Radiomics of magnetic resonance images (MRIs) in rectal cancer can non-invasively characterize tumor heterogeneity with potential to discover new imaging biomarkers. However, for radiomics to be reliable, the imaging features...
5.
Wilson B, Pearson S, Barton M, Amir E
J Natl Compr Canc Netw
. 2022 Aug;
20(8):879-886.e2.
PMID: 35948036
Background: It is unknown how often regional differences in oncology trials are observed. Based on our study findings, we quantified regional variation in registration studies in oncology and developed a...
6.
Batumalai V, Descallar J, Gabriel G, Delaney G, Oar A, Barton M, et al.
Asia Pac J Clin Oncol
. 2022 Jul;
19(2):e149-e159.
PMID: 35844037
Introduction: There is a lack of large population-based studies examining patterns of curative treatment for non-small cell lung cancer (NSCLC) in Australia. This study aimed to evaluate the utilization of...
7.
Delaney G, Barton M
J Med Imaging Radiat Oncol
. 2022 May;
66(6):826-829.
PMID: 35610753
No abstract available.
8.
Elliott M, Amir E, Pearson S, Barton M, Wilson B
Lancet Oncol
. 2022 Jan;
23(1):e1.
PMID: 34973219
No abstract available.
9.
Batumalai V, Descallar J, Wong K, Gabriel G, Delaney G, Shafiq J, et al.
J Med Imaging Radiat Oncol
. 2021 Dec;
66(3):436-441.
PMID: 34862736
Introduction: Trends in the use of short-course radiation therapy (RT) for rectal cancer in Australia are unknown. The purpose of this study was to compare short-course RT and long-course chemoradiation...
10.
Wilson B, Elliott M, Pearson S, Amir E, Barton M
Int J Cancer
. 2021 Aug;
150(1):91-99.
PMID: 34398966
A number of organizations are producing resource stratified guidelines (RSGs) for cancer. Despite using similar definitions of resource levels, systemic treatment recommendations often differ between organizations. We systematically searched for...